Cell Therapeutics reaches agreement with government

Share this article:
Cell Therapeutics has reached agreement with the federal government to pay $10.5 million to resolve the investigation of its business practices in marketing the cancer drug Trisenox (arsenic trioxide). Cell Therapeutics sold Trisenox to Cephalon to finance other drug development efforts.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions